MedMira End Period Cash Flow vs Change To Account Receivables Analysis

MIR Stock

CAD 0.08 0.00 0.00%

MedMira financial indicator trend analysis is infinitely more than just investigating MedMira recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MedMira is a good investment. Please check the relationship between MedMira End Period Cash Flow and its Change To Account Receivables accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MedMira. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

End Period Cash Flow vs Change To Account Receivables

End Period Cash Flow vs Change To Account Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MedMira End Period Cash Flow account and Change To Account Receivables. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between MedMira's End Period Cash Flow and Change To Account Receivables is -0.24. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Change To Account Receivables in the same time period over historical financial statements of MedMira, assuming nothing else is changed. The correlation between historical values of MedMira's End Period Cash Flow and Change To Account Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of MedMira are associated (or correlated) with its Change To Account Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Account Receivables has no effect on the direction of End Period Cash Flow i.e., MedMira's End Period Cash Flow and Change To Account Receivables go up and down completely randomly.

Correlation Coefficient

-0.24

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

End Period Cash Flow

Change To Account Receivables

Most indicators from MedMira's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MedMira current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MedMira. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to climb to about 1.2 M in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	304.0K	300.4K	345.4K	328.2K
Total Revenue	952.1K	432.5K	497.4K	472.5K

Gross Profit Total Revenue

MedMira fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Short Term Investments	Other Stockholder Equity	Current Deferred Revenue	Intangible Assets
Total Assets		0.49	0.52	0.47	-0.23	0.7	0.59	0.14	-0.31	0.73	-0.04	-0.31	0.56	-0.15	0.27	0.29	0.38	0.55	0.74	0.2	-0.15	0.14	0.1	0.0	0.84	0.0
Short Long Term Debt Total	0.49		0.74	0.88	-0.89	0.81	0.7	-0.53	0.09	0.79	-0.53	0.08	0.33	0.55	0.2	-0.37	0.47	0.94	-0.08	0.68	0.46	0.59	0.4	-0.4	0.84	-0.27
Other Current Liab	0.52	0.74		0.82	-0.78	0.81	0.47	-0.45	0.14	0.8	-0.53	0.14	0.64	0.57	0.04	-0.3	0.19	0.83	0.17	0.56	0.41	0.68	0.63	-0.23	0.68	-0.62
Total Current Liabilities	0.47	0.88	0.82		-0.86	0.7	0.6	-0.55	0.1	0.69	-0.46	0.1	0.31	0.59	-0.12	-0.35	0.37	0.93	-0.03	0.81	0.49	0.64	0.41	-0.29	0.72	-0.21
Total Stockholder Equity	-0.23	-0.89	-0.78	-0.86		-0.71	-0.46	0.78	-0.31	-0.67	0.71	-0.31	-0.32	-0.76	-0.16	0.63	-0.34	-0.9	0.32	-0.63	-0.67	-0.75	-0.36	0.46	-0.6	0.31
Property Plant And Equipment Net	0.7	0.81	0.81	0.7	-0.71		0.7	-0.36	-0.11	1.0	-0.36	-0.11	0.72	0.46	0.34	-0.14	0.35	0.82	0.14	0.39	0.29	0.49	0.47	-0.51	0.84	-0.47
Net Debt	0.59	0.7	0.47	0.6	-0.46	0.7		0.09	-0.65	0.73	0.04	-0.65	0.38	0.02	0.03	0.33	0.6	0.59	0.12	0.55	-0.2	0.01	0.19	-0.52	0.73	-0.17
Retained Earnings	0.14	-0.53	-0.45	-0.55	0.78	-0.36	0.09		-0.7	-0.29	0.72	-0.7	-0.16	-0.93	-0.18	0.94	-0.12	-0.6	0.53	-0.32	-0.95	-0.79	-0.26	0.33	-0.18	0.18
Cash	-0.31	0.09	0.14	0.1	-0.31	-0.11	-0.65	-0.7		-0.18	-0.62	1.0	-0.17	0.56	0.18	-0.86	-0.33	0.17	-0.26	-0.04	0.77	0.61	0.17	0.3	-0.13	-0.07
Non Current Assets Total	0.73	0.79	0.8	0.69	-0.67	1.0	0.73	-0.29	-0.18		-0.3	-0.18	0.72	0.4	0.32	-0.07	0.35	0.8	0.18	0.39	0.22	0.43	0.46	-0.51	0.85	-0.47
Non Currrent Assets Other	-0.04	-0.53	-0.53	-0.46	0.71	-0.36	0.04	0.72	-0.62	-0.3		-0.63	-0.17	-0.58	-0.42	0.77	-0.13	-0.6	0.23	-0.16	-0.71	-0.71	-0.28	0.11	-0.33	0.2
Cash And Short Term Investments	-0.31	0.08	0.14	0.1	-0.31	-0.11	-0.65	-0.7	1.0	-0.18	-0.63		-0.17	0.56	0.17	-0.86	-0.33	0.16	-0.26	-0.04	0.77	0.61	0.17	0.3	-0.14	-0.07
Net Receivables	0.56	0.33	0.64	0.31	-0.32	0.72	0.38	-0.16	-0.17	0.72	-0.17	-0.17		0.32	0.41	-0.04	0.23	0.47	0.32	-0.08	0.19	0.44	0.58	-0.42	0.42	-0.59
Common Stock Shares Outstanding	-0.15	0.55	0.57	0.59	-0.76	0.46	0.02	-0.93	0.56	0.4	-0.58	0.56	0.32		0.05	-0.82	0.05	0.61	-0.54	0.39	0.9	0.76	0.53	-0.44	0.18	-0.45
Non Current Liabilities Total	0.27	0.2	0.04	-0.12	-0.16	0.34	0.03	-0.18	0.18	0.32	-0.42	0.17	0.41	0.05		-0.26	0.05	0.24	0.04	-0.57	0.25	0.33	0.13	-0.29	0.25	-0.03
Inventory	0.29	-0.37	-0.3	-0.35	0.63	-0.14	0.33	0.94	-0.86	-0.07	0.77	-0.86	-0.04	-0.82	-0.26		-0.02	-0.44	0.51	-0.13	-0.95	-0.79	-0.26	0.12	-0.01	0.15
Other Current Assets	0.38	0.47	0.19	0.37	-0.34	0.35	0.6	-0.12	-0.33	0.35	-0.13	-0.33	0.23	0.05	0.05	-0.02		0.37	0.15	0.38	0.03	0.1	-0.09	-0.12	0.52	0.09
Total Liab	0.55	0.94	0.83	0.93	-0.9	0.82	0.59	-0.6	0.17	0.8	-0.6	0.16	0.47	0.61	0.24	-0.44	0.37		-0.01	0.58	0.57	0.76	0.49	-0.4	0.79	-0.26
Total Current Assets	0.74	-0.08	0.17	-0.03	0.32	0.14	0.12	0.53	-0.26	0.18	0.23	-0.26	0.32	-0.54	0.04	0.51	0.15	-0.01		-0.09	-0.47	-0.17	-0.04	0.56	0.38	0.04
Short Term Debt	0.2	0.68	0.56	0.81	-0.63	0.39	0.55	-0.32	-0.04	0.39	-0.16	-0.04	-0.08	0.39	-0.57	-0.13	0.38	0.58	-0.09		0.19	0.22	0.16	-0.07	0.51	-0.16
Common Stock	-0.15	0.46	0.41	0.49	-0.67	0.29	-0.2	-0.95	0.77	0.22	-0.71	0.77	0.19	0.9	0.25	-0.95	0.03	0.57	-0.47	0.19		0.85	0.41	-0.25	0.12	-0.2
Accounts Payable	0.14	0.59	0.68	0.64	-0.75	0.49	0.01	-0.79	0.61	0.43	-0.71	0.61	0.44	0.76	0.33	-0.79	0.1	0.76	-0.17	0.22	0.85		0.59	-0.2	0.33	-0.36
Short Term Investments	0.1	0.4	0.63	0.41	-0.36	0.47	0.19	-0.26	0.17	0.46	-0.28	0.17	0.58	0.53	0.13	-0.26	-0.09	0.49	-0.04	0.16	0.41	0.59		-0.23	0.26	-0.82
Other Stockholder Equity	0.0	-0.4	-0.23	-0.29	0.46	-0.51	-0.52	0.33	0.3	-0.51	0.11	0.3	-0.42	-0.44	-0.29	0.12	-0.12	-0.4	0.56	-0.07	-0.25	-0.2	-0.23		-0.15	0.22
Current Deferred Revenue	0.84	0.84	0.68	0.72	-0.6	0.84	0.73	-0.18	-0.13	0.85	-0.33	-0.14	0.42	0.18	0.25	-0.01	0.52	0.79	0.38	0.51	0.12	0.33	0.26	-0.15		-0.16
Intangible Assets	0.0	-0.27	-0.62	-0.21	0.31	-0.47	-0.17	0.18	-0.07	-0.47	0.2	-0.07	-0.59	-0.45	-0.03	0.15	0.09	-0.26	0.04	-0.16	-0.2	-0.36	-0.82	0.22	-0.16

Click cells to compare fundamentals

MedMira Account Relationship Matchups

MedMira fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.4M	3.9M	3.8M	3.7M	3.3M	1.7M
Short Long Term Debt Total	11.9M	11.5M	8.3M	9.3M	10.7M	9.1M
Other Current Liab	3.5M	4.2M	4.5M	5.4M	6.2M	6.5M
Total Current Liabilities	15.8M	17.4M	14.1M	15.7M	18.1M	11.7M
Total Stockholder Equity	(15.6M)	(15.7M)	(12.4M)	(15.0M)	(13.5M)	(14.2M)
Property Plant And Equipment Net	2.5M	2.3M	2.2M	2.0M	2.3M	2.4M
Net Debt	11.5M	13.8M	8.3M	9.3M	10.6M	9.2M
Retained Earnings	(92.8M)	(93.5M)	(95.3M)	(98.0M)	(88.2M)	(92.6M)
Cash	401.9K	(2.3M)	33.5K	13.2K	15.2K	15.9K
Non Current Assets Total	2.5M	2.3M	2.2M	2.0M	2.3M	2.4M
Cash And Short Term Investments	401.9K	(2.3M)	33.5K	13.2K	15.2K	15.9K
Net Receivables	207.8K	1.3M	1.4M	1.4M	1.6M	1.7M
Liabilities And Stockholders Equity	3.4M	3.9M	3.8M	3.7M	3.3M	1.7M
Non Current Liabilities Total	3.2M	2.2M	2.0M	3.0M	2.7M	1.7M
Inventory	222.6K	235.8K	202.0K	182.4K	164.2K	156.0K
Other Current Assets	78.8K	2.4M	53.9K	69.2K	79.6K	75.6K
Total Liab	19.0M	19.6M	16.2M	18.7M	21.5M	13.9M
Total Current Assets	911.1K	1.6M	1.7M	1.7M	1.5M	1.1M
Short Term Debt	8.8M	9.3M	6.3M	6.3M	7.3M	7.3M
Accounts Payable	2.3M	2.7M	2.7M	3.3M	3.8M	2.8M
Other Stockholder Equity	2.7M	7.8K	29.5K	(2.5K)	(2.3K)	(2.1K)
Accumulated Other Comprehensive Income	11.0M	13.8M	13.8M	14.6M	16.8M	17.6M
Current Deferred Revenue	1.2M	1.2M	596.7K	749.9K	862.4K	507.5K
Net Tangible Assets	(13.5M)	(15.6M)	(15.7M)	(12.4M)	(11.1M)	(11.7M)
Short Long Term Debt	8.6M	9.2M	6.1M	6.1M	7.1M	7.1M
Property Plant Equipment	6.7K	2.5M	2.3M	2.2M	2.5M	2.6M
Net Invested Capital	(6.1M)	(6.5M)	(6.2M)	(7.8M)	(7.0M)	(7.3M)
Net Working Capital	(14.9M)	(15.8M)	(12.5M)	(14.0M)	(12.6M)	(13.3M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MedMira Stock Analysis

When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC